Study of medullary thyroid cancer progression in a registry
Part of Cancer clinical trials.
This study follows people with medullary thyroid cancer to better understand how the disease changes over time, including in advanced stages. You may help improve future treatment planning and care for people with medullary thyroid cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with medullary thyroid cancer
- You are enrolled (registered) in the Medullary Thyroid Cancer Registry (MTCR)
- For part of the study, your cancer is considered advanced (red or gray stage) based on the study team’s review
- For the advanced part, you must also be a current MTCR registrant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at what people with medullary thyroid cancer go through during treatment. It aims to understand their experiences to help improve care and support.
This study follows adults who have medullary thyroid cancer (MTC) to learn how the cancer behaves over time. It may help by improving future care and follow-up strategies for people with MTC.
This study collects real-world information from patients with advanced thyroid cancer to better understand how standard treatments and specialized procedures work. Your participation will help improve care for others with this type of cancer.
This study is a registry that collects information about adults with certain types of thyroid cancer. It may help researchers learn more about these cancers and how people are doing over time.
This study looks at a small blood test (called ctDNA) and tumor tissue to understand how advanced thyroid cancers change over time. It may help doctors better monitor cancer growth and guide treatment choices.
This study looks at medical records to see if certain medications might be linked to a rare thyroid cancer (medullary thyroid carcinoma). You don't need to do anything new—just your existing health data will be reviewed.
Hear when a new Advanced Thyroid Gland Medullary Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.